Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. de Laurentiis, G. Scapagnini, D. Paris, D. Melck, M. Maniscalco, A. Motta, S. Matteo, A. Bianco (Naples, Campobasso, Pozzuoli, Somma Vesuviana, Italy). NMR EBC metabonomic to assess the nutricecutic effect in COPD. A pilot study of oral administration of a curcumin based herbal preparation. Eur Respir J 2011; 38: Suppl. 55, 4793

Member's Comments

No comment yet.

Related content which might interest you: Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 A comparative study to evaluate the effects of salmetrol/fluticasone and formoterol/budesonide combinations on lung functions and sleep quality in asthma Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on electronic nose and NMR metabolomic breathprints in patients with COPD Source: International Congress 2016 – Airway biomarkers Year: 2016 The effect of long term treatment with erdosteine on COPD: the Equalife study Source: Eur Respir J 2003; 22: Suppl. 45, 428s Year: 2003 Influence of oral steroid use in difficult-to-control asthma patients on metabolomic profile of oxidative stress in exhaled breath condensate (EXAIR project) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation. Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Are the spacers different in terms of lung bioavailability of salbutamol? An observational comparative study Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Efficacy of erdosteine, carbocysteine, and N-acetylcysteine in COPD: a comparative analysis Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019 NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 A cross-sectional study examining inpatients‘ metered dose inhaler technique and the impact of assessment and education on its effective use Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Design and implementation of a multi-part, flexible protocol to assess the tolerability and pharmacodynamic effects of PUR118 in healthy subjects and COPD patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018 Year: 2018 Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Roflumilast in the treatment of COPD: A pooled safety analysis Source: Annual Congress 2010 - COPD: management Year: 2010 A pilot study to test the feasibility of histological characterisation of asthma–COPD overlap Source: Eur Respir J, 53 (6) 1801941; 10.1183/13993003.01941-2018 Year: 2019 The cost-effectiveness of early intervention with inhaled budesonide once daily: an international comparison of the results from the START study Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002 A double blind placebo controlled study to assess the effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients using novel biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014